Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...

The clinical efficacy of the biologic agents approved for the treatment of RA is also an important consideration when evaluating the cost of therapy, independent of dosing issues. [76] In a ...

The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global ...

Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

Arthritis is a health condition that can cause swelling and tenderness in one or more joints whereas bursitis causes ...

Although Arthritis Today magazine is no longer published, sign up below to receive healthy living tips and resources in our Arthritis Today and other e-newsletters, delivered right to your inbox.

Yes to making connections that count. Yes to advancing research for better treatments and a cure. Connect with and support people living with arthritis either in-person or virtually. Create a better ...

The U.S. Food and Drug Administration (FDA) has accepted for review Biologics License Applications (BLA) for AVT05, ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...